Identificador persistente para citar o vincular este elemento: http://hdl.handle.net/10553/49727
Título: Limitations of insulin-dependent drugs in the treatment of type 2 diabetes mellitus
Autores/as: Valerón, Pino Fuente
De Pablos-Velasco, Pedro L. 
Fecha de publicación: 2013
Editor/a: 0025-7753
Publicación seriada: Medicina Clínica 
Resumen: In this study, we review the efficacy and safety limitations of insulin-dependent oral antidiabetic agents. In terms of efficiency, the main drawback of metformin, sulfonylureas, gliptins and -to a lesser extent-glitazones is durability. No drug per se is able to maintain stable blood glucose control for years. Metformin, sulfonylureas and gliptins have demonstrated safety. Experience with the first two drug groups is more extensive. The main adverse effect of metformin is gastrointestinal discomfort. Major concerns related to the use of sulfonylureas are hypoglycemia and weight gain. The use of pioglitazone has been associated with an increased risk of bladder cancer, edema, heart failure, weight gain, and distal bone fractures in postmenopausal women. The most common adverse reactions associated with glucagon-like peptide-1 agonists are gastrointestinal discomfort that sometimes leads to treatment discontinuation. © 2013 Elsevier España, S.L. All rights reserved.
URI: http://hdl.handle.net/10553/49727
ISSN: 0025-7753
DOI: 10.1016/S0025-7753(13)70059-9
Fuente: Medicina Clinica[ISSN 0025-7753],v. 141, p. 20-25
Colección:Artículos
Vista completa

Google ScholarTM

Verifica

Altmetric


Comparte



Exporta metadatos



Los elementos en ULPGC accedaCRIS están protegidos por derechos de autor con todos los derechos reservados, a menos que se indique lo contrario.